Last checked at 
| Thursday 7 March | |
| Melrose Industries | Full Year Results |
| NMC Health | Full Year Results |
| Aviva | Full Year Results |
| Admiral | Full Year Results |
| Greggs | Full Year Results |
| Funding Circle Holdings | Full Year Results |
| Countrywide | Full Year Results |
| Cobham | Full Year Results |
| C&C Group | Trading Statement |
| Informa | Full Year Results |
| Schroders | Full Year Results |
| CLS Holdings | Full Year Results |
| DS Smith | Trading Statement |
| Alfa Financial Services | Full Year Results |
| Premier Oil | Full Year Results |
| Spirent Communications | Full Year Results |
| Inmarsat | Full Year Results |
| Spirax-Sarco Engineering | Full Year Results |
| Total Produce | Full Year Results |
| Cairn Homes | Full Year Results |
| International Consolidated Airlines | February traffic statistics (at 1500 GMT) |
| Friday 8 March | |
| Bodycote | Full Year Results |
| SIG | Full Year Results |
| Monday 11 March | |
| Clarkson | Full Year Results |
| River & Mercentile | Half Year Results |
| HgCapital Trust | Full Year Results |
| Old Mutual | Full Year Results (at 0900 GMT) |
| Polymetal International | Full Year Results |
| Silence Therapeutics | Full Year Results |
| Tuesday 12 March | |
| G4S | Full Year Results |
| Domino's Pizza Group | Full Year Results |
| Close Brothers | Half Year Results |
| H&T Group | Full Year Results |
| Cairn Energy | Full Year Results |
| Midwich | Full Year Results |
| Pendragon | Full Year Results |
| Purecircle | Full Year Results |
| Surgical Innovations | Full Year Results |
| Equiniti | Full Year Results |
| Global Ports Holdings | Full Year Results |
| Computacenter | Full Year Results |
| French Connection Group | Full Year Results |
| Forterra | Full Year Results |
| 888 Holdings | Full Year Results |
| John Menzies | Full Year Results |
| Gamma Communications | Full Year Results |
| Quilter | Full Year Results |
| Ophir Energy | Full Year Results |
| Wednesday 13 March | |
| Prudential | Full Year Results |
| WM Morrison Supermarkets | Full Year Results |
| Standard Life Aberdeen | Full Year Results |
| Hikma Pharmaceuticals | Full Year Results |
| Dignity | Full Year Results |
| Lookers | Full Year Results |
| Empresaria | Full Year Results |
| Advanced Medical Solutions | Full Year Results |
| Marshall Motor | Full Year Results |
| Provident Financial | Full Year Results |
| Avast Holdings | Full Year Results |
| Balfour Beatty | Full Year Results |
| Burford Capital | Full Year Results |
| Safecharge International | Full Year Results |
| Charles Taylor | Full Year Results |
27 Aug 2021 12:32
Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody
(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.
Read more